# Endava plc: overview

DAVA · NYSE · CIK 1656081 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/dava.md) · [Financials](/companies/dava/financials.md) · [Filings](/companies/dava/filings.md) · [Insiders](/companies/dava/insiders.md)

Latest reported revenue: [GBP 90.5m](/filings/0001656081-20-000016.md) for Q4 FY2020, three months to 2020-06-30, from the 20-F filed Sep 15, 2020 (XBRL ifrs-full:RevenueFromContractsWithCustomers, accession 0001656081-20-000016).

## Last eight quarters

| Line item | Unit | period not labelled (2020-03-31) | Q4 FY2020 (2020-06-30) |
| --- | --- | ---: | ---: |
| Revenue | $m | [92.2](/filings/0001656081-20-000016.md) | [90.5](/filings/0001656081-20-000016.md) |
| Gross margin | % | not reported | not reported |
| Operating margin | % | not reported | not reported |
| Net margin | % | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported |
| Free cash flow | $m | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Net margin (net income / revenue). XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [446](/filings/0001656081-23-000041.md) | [655](/filings/0001656081-24-000037.md) | [795](/filings/0001656081-25-000039.md) | [741](/filings/0001656081-25-000039.md) | [772](/filings/0001656081-25-000039.md) |
| Gross margin | % | [34.5%](/filings/0001656081-23-000041.md) | [33.3%](/filings/0001656081-24-000037.md) | [33.2%](/filings/0001656081-25-000039.md) | [24.3%](/filings/0001656081-25-000039.md) | [25.1%](/filings/0001656081-25-000039.md) |
| Operating margin | % | [14.2%](/filings/0001656081-23-000041.md) | [14.6%](/filings/0001656081-24-000037.md) | [14.2%](/filings/0001656081-25-000039.md) | [2.7%](/filings/0001656081-25-000039.md) | [4.1%](/filings/0001656081-25-000039.md) |
| Net margin | % | [9.7%](/filings/0001656081-23-000041.md) | [12.7%](/filings/0001656081-24-000037.md) | [11.8%](/filings/0001656081-25-000039.md) | [2.3%](/filings/0001656081-25-000039.md) | [2.7%](/filings/0001656081-25-000039.md) |
| Diluted EPS | $ per share | [0.76](/filings/0001656081-23-000041.md) | [1.43](/filings/0001656081-24-000037.md) | [1.62](/filings/0001656081-25-000039.md) | [0.29](/filings/0001656081-25-000039.md) | [0.36](/filings/0001656081-25-000039.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:RevenueFromContractsWithCustomers.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dava/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Prescott Group Capital Management, L.L.C.](/funds/1166152.md) | 2026-06-30 | $9.1m | 3,200,921 |  | Added +1,608,367 |
| [Paradice Investment Management LLC](/funds/1620275.md) | 2026-06-30 | $8.3m | 2,948,635 |  | Reduced −30,633 |
| [CDAM (UK) Ltd](/funds/1719387.md) | 2026-06-30 | $6.7m | 2,374,626 |  | Reduced −574,946 |
| [Alberta Investment Management Corp](/funds/1463559.md) | 2026-06-30 | $2.1m | 726,315 |  | Reduced −223,685 |
| [Kerrisdale Advisers, LLC](/funds/1569688.md) | 2026-06-30 | $1.6m | 567,416 |  | Unchanged |
| [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $1.5m | 518,656 |  | Added +401 |
| [Rathbones Group PLC](/funds/1351991.md) | 2026-06-30 | $1.0m | 360,823 |  | Unchanged |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $877.8k | 310,181 |  | Reduced −84,857 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $533.1k | 188,375 |  | Reduced −2,658 |
| [PEAK6 LLC](/funds/1389958.md) | 2026-06-30 | $436.7k | 154,300 | Call | New +154,300 |

## Recent filings

[All 281 filings](/companies/dava/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 08:26 ET | [6-K](/filings/0001193125-26-435193.md) | Report of a foreign private issuer, period 2026-10-28 | 0001193125-26-435193 |
| 2026-09-21 | 17:06 ET | [6-K](/filings/0001193125-26-396797.md) | Report of a foreign private issuer, period 2026-09-21 | 0001193125-26-396797 |
| 2026-05-21 | 07:21 ET | [6-K](/filings/0001656081-26-000015.md) | Report of a foreign private issuer, period 2026-03-31 | 0001656081-26-000015 |
| 2026-03-30 | 06:22 ET | [6-K](/filings/0001656081-26-000010.md) | Report of a foreign private issuer, period 2025-12-31 | 0001656081-26-000010 |
| 2026-02-19 | 07:19 ET | [6-K](/filings/0001656081-26-000005.md) | Report of a foreign private issuer, period 2025-12-31 | 0001656081-26-000005 |
| 2025-12-11 | 08:44 ET | [6-K](/filings/0001656081-25-000059.md) | Report of a foreign private issuer, period 2025-12-12 | 0001656081-25-000059 |
| 2025-11-12 | 16:17 ET | [6-K](/filings/0001656081-25-000056.md) | Report of a foreign private issuer, period 2025-11-13 | 0001656081-25-000056 |
| 2025-11-12 | 06:02 ET | [6-K](/filings/0001656081-25-000050.md) | Report of a foreign private issuer, period 2025-09-30 | 0001656081-25-000050 |
| 2025-09-10 | 07:07 ET | [6-K](/filings/0001656081-25-000046.md) | Report of a foreign private issuer, period 2025-06-30 | 0001656081-25-000046 |
| 2025-09-04 | 07:22 ET | [20-F](/filings/0001656081-25-000039.md) | Annual report of a foreign private issuer, period 2025-06-30 | 0001656081-25-000039 |

## Latest annual report

[Form 20-F for the fiscal year ended Jun 30, 2025](/filings/0001656081-25-000039.md), filed Sep 4, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1656081
- Tickers: DAVA
- Exchange: NYSE
- SIC code: 7371 Services-Computer Programming Services
- State of incorporation: X0
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 08:27 ET. No prices; not investment advice.